Xerostomia after radiotherapy and its effect on quality of life in head and neck cancer patients

Archives of Iranian Medicine

Volumn 15, Issue 4, 2012, Pages 214-218

  Kakoei, Shahla ^a   Haghdoost, Ali Akbar ^b   Rad, Maryam ^c   Mohammadalizadeh, Sakineh ^d   Pourdamghan, Nasim ^e   Nakhaei, Mahdieh ^a   Bahador, Maryam ^f  

^a KERMAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b KERMAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c KERMAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^d Razi Nursing School   (Iran)

^e General Practitioner   (Iran)

^f IRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Quality of life; Radiotherapy; Saliva flow; Xerostomia

Indexed keywords

CISPLATIN;

ADULT; ARTICLE; BRAIN CANCER; CANCER PATIENT; CANCER RADIOTHERAPY; DISEASE ASSOCIATION; DISEASE SEVERITY; EAR CANCER; FEMALE; HEAD AND NECK CANCER; HUMAN; IRAN; LARYNX CANCER; LONGITUDINAL STUDY; LYMPHOMA; MAJOR CLINICAL STUDY; MALE; MOUTH CANCER; OROPHARYNX CANCER; OUTCOME ASSESSMENT; PROSPECTIVE STUDY; QUALITY OF LIFE; REGRESSION ANALYSIS; SALIVA ANALYSIS; SALIVARY GLAND CANCER; SALIVATION; XEROSTOMIA; ANALYSIS OF VARIANCE; HEAD AND NECK TUMOR; MIDDLE AGED; PHYSIOLOGY; QUESTIONNAIRE; RADIATION EXPOSURE; RADIOTHERAPY; SALIVA; SALIVARY GLAND; SECRETION;

ADULT; ANALYSIS OF VARIANCE; FEMALE; HEAD AND NECK NEOPLASMS; HUMANS; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; QUALITY OF LIFE; QUESTIONNAIRES; RADIOTHERAPY; SALIVA; SALIVARY GLANDS; SALIVATION; XEROSTOMIA;

EID: 84862264759     PISSN: 10292977     EISSN: 17353947     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. thed. Ontario, BC: Decker Inc., 2008; 153-190.
2. nd ed. New Delhi: Jaypee Brothers; 2005: 187-196.
3. Dirix P, Nuyts S, Vander Poorten V, Delaere P, Van den Bogaert W. The influence of xerostomia after radiotherapy on quality of life: results of a questionnaire in head and neck cancer. Support Care Cancer 2008; 16: 171-179.
4. Pow EH, Kwong DL, McMillan AS, Wong MC, Sham JS, Leung LH, et al. Xerostomia and quality of life after intensity-modulated radiotherapy vs. conventional radiotherapy for early-stage nasopharyngeal carcinoma: initial report on a randomized controlled clinical trial. Int J Radiat Oncol Biol Phys. 2006; 66: 981-991.
5. Liu XK, Zeng ZY, Hong MH, Zhang AL, Cui NJ, Chen FJ. Clinical analysis of xerostomia in patients with nasopharyngeal carcinoma after radiation therapy [in Chinese]. AiZheng. 2004; 23: 593-596.
6. Brosky ME. The role of saliva in oral health: strategies for prevention and management of xerostomia. J Support Oncol. 2007; 5: 228-229.
7. Oates JE, Clark JR, Read J, Reeves N, Gao K, Jackson M, et al. Prospective evaluation of quality of life and nutrition before and after treatment for nasopharyngeal carcinoma. Arch Otolaryngol head Neck Surg. 2007; 133: 533-540.
8. Jham BC, da Silva Freire AR. Oral complications of radiotherapy in the head and neck. Braz J Otorhinolaryngol. 2006; 72: 704-708.
9. Carl W. Local radiation and systemic chemotherapy: preventing and managing the oral complications. J Am Dent Assoc. 1993; 124: 119-123.
10. Andrews N, Griffiths C. Dental complications of head and neck radiotherapy: Part 1. Aust Dent J. 2001; 46: 88-94.
11. th ed. Philadelphia: Lippincott, Williams & Wilkins; 2001: 2881.
12. Wu Y, Hu WH, Xia YF, Ma J, Liu MZ, Cui NJ. Quality of life of na-sopharyngeal carcinoma survivors in Mainland China. Qual Life Res. 2007; 16: 65-74.
13. Guobis Z, Baseviciene N, Paipaliene P, Sabalys G, Kubilius R. Xerostomia: clinic, etiology, diagnosis and treatment. Medicina (Kaunas). 2006; 42: 171-179.
14. Shahdad SA, Taylor C, Barclay SC, Steen IN, Preshaw PM. A double-blind, crossover study of Biotene Oralbalance and BioXtra systems as salivary substitutes in patients with post-radiotherapy xerostomia. Eur J Cancer Care (Engl). 2005; 14: 319-326.
15. Sahba S, Ghadimi S, Talaeepour A-R, Hadad P, Zolfaghari E. The efficacy of Iranian made saliva substitute vs. VA-OraLube in improvement of oral health-related quality of life in radiotherapy-induced xerostomia. J Dent Sch Shahid Beheshti Univ Med Sci. 2009; 3: 136-145.
16. Eisbruch A, Kim HM, Terrell JE, Marsh LH, Dawson LA, Ship JA. Xerostomia and its predictors following parotid-sparing irradiation of head and neck cancer. Int JRadiat Oncol Biol Phys. 2001; 50: 695-704.
17. Lin SC, Jen YM, Chang YC, Lin CC. Assessment of xerostomia and its impact on quality of life in head and neck cancer patients undergoing radiotherapy, and validation of the Taiwanese version of the xerostomia questionnaire. J Pain Symptom Manage. 2008; 36: 141-148.
18. Momm F, Volegova-Neher NJ, Schulte-Mönting J, Guttenberger R. Different saliva substitutes for treatment of xerostomia following radiotherapy. A prospective crossover study. Strahlenther Onkol 2005; 181: 231-236.
19. Guchelaar H, Vermes A, Meerwaldt J. Radiation-induced xerostomia: pathophysiology, clinical course and supportive treatment. Support Care Cancer. 1997; 5: 281-288.
20. Cassolato SF, Turnbull RS. Xerostomia: clinical aspects and treatment. Gerodontology. 2003; 20: 64-77.
21. Chambers MS, Rosenthal DI, Weber RS. Radiation-induced xerostomia. Head Neck. 2007; 29: 58-63.
22. Garg AK, Malo M. Manifestations and treatment of xerostomia and associated oral effects secondary to head and neck radiation therapy. J Am Dent Assoc. 1997; 128: 1128-1133.
23. Visvanathan V, Nix P. Managing the patient presenting with xerostomia: a review. Int J Clin Pract. 2010; 64: 404-407.
24. Shiboski CH, Hodgson TA, Ship JA, Schiodt M. Management of salivary hypofunction during and after radiotherapy. Oral Surg Oral Med Pathol Oral Radiol Endod. 2007; 103: 1-19.
25. Hahn TR, Kruskemper G. The impact of radiotherapy on quality of life-a survey of 1411 patient with oral cancer. Mund Kiefer Gesich-tschir. 2007; 11: 99-106.
26. McMillan AS, Pow EH, Leung WK, Kwong DL, Wong MC. Oral health condition in southern Chinese after radiotherapy for nasopha-ryngeal carcinoma: Extent and nature of the problem. OralDis. 2003; 9: 196-202